Literature DB >> 29080682

Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability.

Mugdha Sawant1, Nicole Schwarz1, Reinhard Windoffer1, Thomas M Magin2, Jan Krieger3, Norbert Mücke3, Boguslaw Obara4, Vera Jankowski5, Joachim Jankowski6, Verena Wally7, Thomas Lettner7, Rudolf E Leube8.   

Abstract

A characteristic feature of the skin blistering disease epidermolysis bullosa simplex is keratin filament (KF) network collapse caused by aggregation of the basal epidermal keratin type II (KtyII) K5 and its type I partner keratin 14 (K14). Here, we examine the role of keratin phosphorylation in KF network rearrangement and cellular functions. We detect phosphorylation of the K5 head domain residue T150 in cytoplasmic epidermolysis bullosa simplex granules containing R125C K14 mutants. Expression of phosphomimetic T150D K5 mutants results in impaired KF formation in keratinocytes. The phenotype is enhanced upon combination with other phosphomimetic K5 head domain mutations. Remarkably, introduction of T150D K5 mutants into KtyII-lacking (KtyII-/-) keratinocytes prevents keratin network formation altogether. In contrast, phosphorylation-deficient T150A K5 leads to KFs with reduced branching and turnover. Assembly of T150D K5 is arrested at the heterotetramer stage coinciding with increased heat shock protein association. Finally, reduced cell viability and elevated response to stressors is noted in T150 mutant cells. Taken together, our findings identify T150 K5 phosphorylation as an important determinant of KF network formation and function with a possible role in epidermolysis bullosa simplex pathogenesis.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29080682     DOI: 10.1016/j.jid.2017.10.011

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer.

Authors:  Olivia McGinn; Duncan Riley; Jessica Finlay-Schultz; Kiran V Paul; Peter Kabos; Carol A Sartorius
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

2.  Assembly Kinetics of Vimentin Tetramers to Unit-Length Filaments: A Stopped-Flow Study.

Authors:  Norbert Mücke; Lara Kämmerer; Stefan Winheim; Robert Kirmse; Jan Krieger; Maria Mildenberger; Jochen Baßler; Ed Hurt; Wolfgang H Goldmann; Ueli Aebi; Katalin Toth; Jörg Langowski; Harald Herrmann
Journal:  Biophys J       Date:  2018-05-10       Impact factor: 4.033

3.  Regulation of keratin network dynamics by the mechanical properties of the environment in migrating cells.

Authors:  Anne Pora; Sungjun Yoon; Georg Dreissen; Bernd Hoffmann; Rudolf Merkel; Reinhard Windoffer; Rudolf E Leube
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

4.  The focal adhesion scaffold protein Hic-5 regulates vimentin organization in fibroblasts.

Authors:  Rishel B Vohnoutka; Anushree C Gulvady; Gregory Goreczny; Kyle Alpha; Samuel K Handelman; Jonathan Z Sexton; Christopher E Turner
Journal:  Mol Biol Cell       Date:  2019-10-23       Impact factor: 4.138

5.  A Novel Mutation p.L461P in KRT5 Causing Localized Epidermolysis Bullosa Simplex.

Authors:  Xin Jiang; Yingyu Zhu; Huihui Sun; Feng Gu
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444

6.  A mathematical model for the dependence of keratin aggregate formation on the quantity of mutant keratin expressed in EGFP-K14 R125P keratinocytes.

Authors:  Marcos Gouveia; Tjaša Sorčan; Špela Zemljič-Jokhadar; Rui D M Travasso; Mirjana Liović
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

Review 7.  Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.

Authors:  Nadezhda A Evtushenko; Arkadii K Beilin; Anastasiya V Kosykh; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.